Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation (Q82286516)

From Wikidata

Jump to navigation Jump to search

scientific article published on 14 October 2008

Language	Label	Description	Also known as
English	Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation	scientific article published on 14 October 2008

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

prostate cancer

1 reference

based on heuristic

inferred from title

Daniel A Galvão

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Dennis R. Taaffe

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

N Spry

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

D Joseph

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

D Turner

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

R U Newton

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

14 October 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Prostate Cancer and Prostatic Diseases

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

198-203

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

https://scigraph.springernature.com/pub.10.1038/pcan.2008.51

0 references

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

National practice patterns and time trends in androgen ablation for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Insulin sensitivity during combined androgen blockade for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Sarcopenia: origins and clinical relevance

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Once-weekly resistance exercise improves muscle strength and neuromuscular performance in older adults

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Resistance exercise dosage in older adults: single- versus multiset effects on physical performance and body composition

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

High-intensity strength training in nonagenarians. Effects on skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Lower extremity physical performance and hip bone mineral density in elderly black and white men and women: cross-sectional associations in the Health ABC Study

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Estimating cardiorespiratory fitness in well-functioning older adults: treadmill validation of the long distance corridor walk

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Association of Long-Distance Corridor Walk Performance With Mortality, Cardiovascular Disease, Mobility Limitation, and Disability

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Measuring Fitness in Healthy Older Adults: The Health ABC Long Distance Corridor Walk

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Quantifying the effect of hand preference on upper limb bone mineral and soft tissue composition in young and elderly women by dual-energy X-ray absorptiometry.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Physical function in men with prostate cancer on androgen deprivation therapy

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Physical function changes in prostate cancer patients on androgen deprivation therapy: a 2-year prospective study

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Exercise capacity and mortality among men referred for exercise testing.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Long-term effects of androgen deprivation therapy in prostate cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Osteoporosis during androgen deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Changes in bone mineral density and body composition during initial and long-term gonadotropin-releasing hormone agonist treatment for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Quality of life, morbidity, and mortality after low trauma hip fracture in men.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Endocrine and immune responses to resistance training in prostate cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Resistance Training and Reduction of Treatment Side Effects in Prostate Cancer Patients

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Identifiers

10.1038/PCAN.2008.51

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82286516&oldid=2005448033"